Signaturefd LLC Sells 173 Shares of HealthEquity, Inc. (NASDAQ:HQY)

Signaturefd LLC reduced its stake in HealthEquity, Inc. (NASDAQ:HQY) by 13.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,160 shares of the company’s stock after selling 173 shares during the quarter. Signaturefd LLC’s holdings in HealthEquity were worth $111,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in the stock. Intech Investment Management LLC grew its position in HealthEquity by 59.5% during the 3rd quarter. Intech Investment Management LLC now owns 21,064 shares of the company’s stock valued at $1,724,000 after purchasing an additional 7,859 shares during the last quarter. Massachusetts Financial Services Co. MA grew its holdings in shares of HealthEquity by 7.4% during the third quarter. Massachusetts Financial Services Co. MA now owns 484,782 shares of the company’s stock valued at $39,679,000 after buying an additional 33,523 shares during the last quarter. Charles Schwab Investment Management Inc. grew its holdings in shares of HealthEquity by 1.4% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,061,807 shares of the company’s stock valued at $86,909,000 after buying an additional 14,532 shares during the last quarter. Raymond James Trust N.A. increased its position in shares of HealthEquity by 4.8% during the third quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock valued at $238,000 after acquiring an additional 132 shares in the last quarter. Finally, Citigroup Inc. raised its holdings in HealthEquity by 73.0% in the 3rd quarter. Citigroup Inc. now owns 102,107 shares of the company’s stock worth $8,357,000 after acquiring an additional 43,084 shares during the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Price Performance

Shares of NASDAQ:HQY opened at $84.88 on Monday. The company has a market capitalization of $7.36 billion, a P/E ratio of 77.87, a P/E/G ratio of 1.60 and a beta of 0.62. HealthEquity, Inc. has a 1-year low of $65.01 and a 1-year high of $115.59. The firm’s 50 day simple moving average is $104.90 and its two-hundred day simple moving average is $95.76. The company has a debt-to-equity ratio of 0.51, a current ratio of 3.20 and a quick ratio of 3.20.

Insider Activity at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the stock in a transaction dated Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares in the company, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 2.20% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts have commented on HQY shares. Barrington Research reissued an “outperform” rating and issued a $112.00 target price on shares of HealthEquity in a report on Friday, March 14th. Wells Fargo & Company lifted their price objective on HealthEquity from $110.00 to $125.00 and gave the stock an “overweight” rating in a report on Wednesday, February 26th. Mizuho started coverage on shares of HealthEquity in a research note on Wednesday, December 4th. They set an “outperform” rating and a $126.00 target price on the stock. JMP Securities raised their price target on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a report on Tuesday, December 10th. Finally, Royal Bank of Canada boosted their price objective on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a report on Tuesday, December 10th. One equities research analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to data from MarketBeat, HealthEquity has an average rating of “Moderate Buy” and an average price target of $112.92.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.